Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Prostate Cancer treatment details. Biologic therapy. University of Chicago, Chicago, Illinois, United States



Survival: 15.3 months
   
Toxicity Grade: 4
   
Treatments: Biologic therapy
   
Drugs:
Country: United States
   
City/State/Province: Chicago, Illinois
   
Hospital: University of Chicago
   
Journal: Link
   
Date: 1/2004

Description:
Patients: This Phase II trial involved 58 patients with hormone refractory prostate cancer. Median age was 72 years. All patients had received previous hormone therapy, 38 patients had received prior radiotherapy, and 42 patients had received prior surgery.

Treatment: The treatment consisted of Suramin (a drug typically used against trypanosomiasis sleeping sickness).

Toxicity: Grade 3 or 4 toxicities included edema, elevated alkaline phosphatase, hematologic, bilirubin, pain, fatigue, anorexia, diarrhea, and respiratory.

Results: Median survival was 15.3 months.

Correspondence: Nicholas J. Vogelzang, MD

E-mail to a Friend Email Physician More Information